Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

BACKGROUND: Proprotein convertase subtilisin/kexin 9 (PCSK9) has been proposed as a novel target for coronary artery disease (CAD). Familial hypercholesterolemia (FH) is characterized by high prevalence of CAD and major cardiovascular events (MACEs). However, no data is available on the association...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Cao, Ye-Xuan, Jin, Jing-Lu, Sun, Di, Liu, Hui-Hui, Guo, Yuan-Lin, Wu, Na-Qiong, Xu, Rui-Xia, Zhu, Cheng-Gang, Dong, Qian, Sun, Jing, Li, Jian-Jun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849213/
https://ncbi.nlm.nih.gov/pubmed/31711505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2123-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars